To evaluate the effect of IL1RAP on the development of atherosclerosis, we administered a blocking non-depleting (LALA-PG modified) anti-IL1RAP antibody or isotype control IgG to Apoe−/− mice. The gene discussed is APOE; the disease is atherosclerosis.